相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens
Chengcheng Zou et al.
JOURNAL OF VIROLOGY (2019)
VACCINOLOGY Structural topology defines protective CD8+ T cell epitopes in the HIV proteome
Gaurav D. Gaiha et al.
SCIENCE (2019)
Lessons for general vaccinology research from attempts to develop an HIV vaccine
Stuart Z. Shapiro
VACCINE (2019)
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
Christine A. Bricault et al.
CELL HOST & MICROBE (2019)
Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy
Joanna A. Warren et al.
FRONTIERS IN IMMUNOLOGY (2019)
Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)
Beatriz Mothe et al.
ECLINICALMEDICINE (2019)
Passive and active antibody studies in primates to inform HIV vaccines
Ann J. Hessell et al.
EXPERT REVIEW OF VACCINES (2018)
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
Peter D. Kwong et al.
IMMUNITY (2018)
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial
Youyi Fong et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones
Arumugam Balamurugan et al.
JOURNAL OF VIROLOGY (2018)
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Dan H. Barouch et al.
LANCET (2018)
CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication
Hayato Murakoshi et al.
RETROVIROLOGY (2018)
Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire
Katherine L. Williams et al.
CELL REPORTS (2018)
Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors
Steven Tuyishime et al.
EBIOMEDICINE (2018)
A campaign to end AIDS by 2030 is faltering worldwide
Jon Cohen
SCIENCE (2018)
Recent progress in broadly neutralizing antibodies to HIV
Devin Sok et al.
NATURE IMMUNOLOGY (2018)
Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?
Lais Teodoro da Silva et al.
FRONTIERS IN IMMUNOLOGY (2018)
Progress toward active or passive HIV-1 vaccination
Amelia Escolano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The quest for an antibody-based HIV vaccine
Barton F. Haynes et al.
IMMUNOLOGICAL REVIEWS (2017)
Complex immune correlates of protection in HIV-1 vaccine efficacy trials
Georgia D. Tomaras et al.
IMMUNOLOGICAL REVIEWS (2017)
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial
Holly E. Janes et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
THE VACCINE WARS
Meredith Wadman et al.
SCIENCE (2017)
Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines
Nicola Borthwick et al.
PLOS ONE (2017)
Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition
Peter J. Hayes et al.
AIDS (2016)
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Dennis R. Burton et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition
Sultan Abdul-Jawad et al.
MOLECULAR THERAPY (2016)
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection
Beatrice Ondondo et al.
MOLECULAR THERAPY (2016)
Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E
Scott G. Hansen et al.
SCIENCE (2016)
A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial
T. Hertz et al.
VACCINE (2016)
Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells (vol 7, e00473-16, 2016)
Kellie N. Smith et al.
MBIO (2016)
Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine
James Theiler et al.
SCIENTIFIC REPORTS (2016)
Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells (vol 7, e00473, 2016)
Kellie N. Smith et al.
MBIO (2016)
A Proposal to Use Iterative, Small Clinical Trials to Optimize Therapeutic HIV Vaccine Immunogens to Launch Therapeutic HIV Vaccine Development
Stuart Z. Shapiro
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
Natural Evolution of Broadly Neutralizing Antibodies
Galit Alter et al.
CELL (2015)
An interactive web application for the dissemination of human systems immunology data
Cate Speake et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost
Sandrine L. Hulot et al.
JOURNAL OF VIROLOGY (2015)
Short Conserved Sequences of HIV-1 Are Highly Immunogenic and Shift Immunodominance
Otto O. Yang et al.
JOURNAL OF VIROLOGY (2015)
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2h HVTN 503/Phambili study
Glenda E. Gray et al.
LANCET INFECTIOUS DISEASES (2014)
Phambili: moving forward without the blindfold
Nelson L. Michael et al.
LANCET INFECTIOUS DISEASES (2014)
Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1
Nicola Borthwick et al.
MOLECULAR THERAPY (2014)
HIV-1 Conserved Elements p24CE DNA Vaccine Induces Humoral Immune Responses with Broad Epitope Recognition in Macaques
Viraj Kulkarni et al.
PLOS ONE (2014)
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
Dan H. Barouch et al.
CELL (2013)
HIV-1 neutralizing antibodies: understanding nature's pathways
John R. Mascola et al.
IMMUNOLOGICAL REVIEWS (2013)
Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection
Holly Janes et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
HIV-1 p24gag Derived Conserved Element DNA Vaccine Increases the Breadth of Immune Response in Mice
Viraj Kulkarni et al.
PLOS ONE (2013)
Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms
Scott G. Hansen et al.
SCIENCE (2013)
The history of antiretroviral therapy and of its implementation in resource-limited areas of the world
Stefano Vella et al.
AIDS (2012)
Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)
Ann Duerr et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Virus Inhibition Activity of Effector Memory CD8+ T Cells Determines Simian Immunodeficiency Virus Load in Vaccinated Monkeys after Vaccine Breakthrough Infection
Takuya Yamamoto et al.
JOURNAL OF VIROLOGY (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Definition of the viral targets of protective HIV-1-specific T cell responses
Beatriz Mothe et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
Morgane Rolland et al.
NATURE MEDICINE (2011)
HIV-1 Vaccine Development After STEP
Dan H. Barouch et al.
ANNUAL REVIEW OF MEDICINE (2010)
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
Dan H. Barouch et al.
NATURE MEDICINE (2010)
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
Sampa Santra et al.
NATURE MEDICINE (2010)
Antiviral CD8(+) T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6
M. Genesca et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge
Nancy A. Wilson et al.
JOURNAL OF VIROLOGY (2009)
T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces
Bette T. Korber et al.
JOURNAL OF VIROLOGY (2009)
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
Jinyan Liu et al.
NATURE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Targeting of a CD8 T cell Env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure
K. C. Ngumbela et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Web-based design and evaluation of T-cell vaccine candidates
James Thurmond et al.
BIOINFORMATICS (2008)
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults
Frances H. Priddy et al.
CLINICAL INFECTIOUS DISEASES (2008)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults
Geoffrey J. Gorse et al.
VACCINE (2008)
Safety and immunogenicity of recombinant low-dosage HIV-1 a vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa
Walter Jaoko et al.
VACCINE (2008)
Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIVKU2 infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail
Pramod N. Nehete et al.
VIROLOGY (2008)
Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States
Sandra W. Roush et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
Sven Letourneau et al.
PLOS ONE (2007)
CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load
Photini Kiepiela et al.
NATURE MEDICINE (2007)
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
Will Fischer et al.
NATURE MEDICINE (2007)
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine
Barney S. Graham et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1
CC Wilson et al.
JOURNAL OF IMMUNOLOGY (2003)
A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques
EGT Wee et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
BD Livingston et al.
VACCINE (2001)
分享论文
